Literature DB >> 16236080

Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults.

D Erdogan1, H Gullu, M Caliskan, E Yildirim, M Bilgi, T Ulus, N Sezgin, H Muderrisoglu.   

Abstract

Although uric acid (UA) is considered as an antioxidant, the relationship between serum UA levels and cardiovascular diseases is not clear yet. Higher brachial artery resting diameter (BD), impaired brachial artery flow-mediated dilatation (FMD), increased carotid intima-media thickness (IMT), decreased aortic distensibility (AoD), and increased aortic stiffness index (AoSI) and elastic modulus (AoEM) are predictors for development and/or progression of atherosclerosis. In this study, BD, FMD, carotid IMT, AoD, AoSI and AoEM were studied in healthy subjects with UA concentrations in physiological range. One hundred 24 healthy volunteers between 26 and 55 years of age were included in this study. Each subject had a serum UA levels in normal range. Carotid IMT, BD and brachial FMD were measured by means of high-resolution vascular ultrasound. AoD, AoSI, AoEM were examined by transthoracic echocardiography. Endothelium-dependent dilatation (EDD) was assessed by establishing reactive hyperemia and endothelium-independent dilatation (EID) was determined by using sublingual isosorbide dinitrate. Although carotid IMT and EDD were significantly correlated with UA concentrations (r = 0.346, p < 0.0001; r = -0.255, p < 0.05, respectively), EID measurements were not significantly correlated with serum UA concentrations (r = - 0.105, p > 0.05). In addition, AoSI and AoEM were significantly correlated with serum UA levels (r = 0.368, p < 0.0001; r = -0.366, p < 0.0001, respectively), and there was a significant inverse correlation between AoD and serum UA concentrations (r = -0.366, p < 0.0001). Furthermore, in multivariate analysis, we found that serum UA concentrations were correlated with increased carotid IMT, reduced FMD and increased aortic stiffness independent of other cardiovascular risk factor (beta = 256, p = 0.002; beta = -193, p = 0.03; beta = 0.295, p < 0.0001, respectively). In healthy subjects, increased serum UA concentrations, even in physiological range, are a risk factor for increased carotid IMT, reduced FMD and increased aortic stiffness independent of other cardiovascular risk factor, and other factors related to the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236080     DOI: 10.1111/j.1742-1241.2005.00621.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  42 in total

1.  Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome.

Authors:  Mélanie Gaubert; Marion Marlinge; Marine Alessandrini; Marc Laine; Laurent Bonello; Julien Fromonot; Jennifer Cautela; Franck Thuny; Jeremie Barraud; Giovanna Mottola; Pascal Rossi; Emmanuel Fenouillet; Jean Ruf; Régis Guieu; Franck Paganelli
Journal:  Purinergic Signal       Date:  2018-04-06       Impact factor: 3.765

2.  Association among serum uric acid, cardiovascular risk, and arterial stiffness: a cross-sectional study in She ethnic minority group of Fujian Province in China.

Authors:  Y Lin; X Lai; G Chen; Y Xu; B Huang; Y Wu; Z Chen; L Yao; F Lin; Y Qiao; Z Chen; S Zhu; H Huang; J Wen
Journal:  J Endocrinol Invest       Date:  2011-05-30       Impact factor: 4.256

Review 3.  Effects of Allopurinol on Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.

Authors:  Arrigo F G Cicero; Matteo Pirro; Gerald F Watts; Dimitri P Mikhailidis; Maciej Banach; Amirhossein Sahebkar
Journal:  Drugs       Date:  2018-01       Impact factor: 9.546

4.  Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations.

Authors:  Laura Gabriela Sánchez-Lozada; Miguel A Lanaspa; Magdalena Cristóbal-García; Fernando García-Arroyo; Virgilia Soto; David Cruz-Robles; Takahiko Nakagawa; Min A Yu; Duk-Hee Kang; Richard J Johnson
Journal:  Nephron Exp Nephrol       Date:  2012-12-07

5.  Determinants of vascular function in patients with chronic gout.

Authors:  Robert D Brook; Srilakshmi Yalavarthi; James D Myles; Shokoufeh Khalatbari; Rita Hench; Susan Lustig; Wendy Marder; Adam Neidert; Mariana J Kaplan
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-22       Impact factor: 3.738

6.  Uric acid level and erectile dysfunction in patients with coronary artery disease.

Authors:  Yalcin Solak; Hakan Akilli; Mehmet Kayrak; Alpay Aribas; Abduzhappar Gaipov; Suleyman Turk; Santos E Perez-Pozo; Adrian Covic; Kim McFann; Richard J Johnson; Mehmet Kanbay
Journal:  J Sex Med       Date:  2013-09-25       Impact factor: 3.802

7.  Serum urate levels and the risk of hip fractures: data from the Cardiovascular Health Study.

Authors:  Tapan Mehta; Petra Bůžková; Mark J Sarnak; Michel Chonchol; Jane A Cauley; Erin Wallace; Howard A Fink; John Robbins; Diana Jalal
Journal:  Metabolism       Date:  2014-11-21       Impact factor: 8.694

8.  Is lower uric acid level better? A combined cross-sectional and longitudinal study in the elderly.

Authors:  Chang-Hsun Hsieh; Jiunn-Diann Lin; Chung-Ze Wu; Chun-Hsien Hsu; Dee Pei; Yao-Jen Liang; Yen-Lin Chen
Journal:  Endocrine       Date:  2014-02-21       Impact factor: 3.633

9.  Uric acid is an independent predictor of arterial stiffness in hypertensive patients.

Authors:  Wei-Chuan Tsai; Yao-Yi Huang; Chih-Chan Lin; Wei-Ting Li; Cheng-Han Lee; Ju-Yi Chen; Jyh-Hong Chen
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

10.  Predictive Value of Elevated Uric Acid in Turkish Patients Undergoing Primary Angioplasty for ST Elevation Myocardial Infarction.

Authors:  Ozgur Akgul; Huseyin Uyarel; Hamdi Pusuroglu; Mehmet Gul; Nilgun Isiksacan; Selahattin Turen; Mehmet Erturk; Ozgur Surgit; Mustafa Cetin; Umit Bulut; Omer Faruk Baycan; Nevzat Uslu
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.